There's a biotech stock on Josh Brown's list that's ignoring the market noise and pushing higher
- Posted on September 17, 2026
- By CNBC
- 1 Views
- 1 min read
In brief
Financial analysts Josh Brown and Sean Russo examine a resilient biotech company featured in their curated investment portfolio that continues gaining momentum despite broader market volatility. This analysis explores the stock's performance drivers, competitive positioning, and fundamental strengths that distinguish it from sector headwinds, providing investors with insights into why this healthcare innovation play maintains upward trajectory amidst uncertain economic conditions.
Summary auto-generated by AI from the original publisher's content. Editorial standards.
There's a biotech stock on Josh Brown's list that's ignoring the market noise and pushing higher
Josh Brown and Sean Russo break down what's going on with this biotech name on their Best Stocks list.
